Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy.
about
Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysisMutation detection using plasma circulating tumor DNA (ctDNA) in a cohort of asymptomatic adults at increased risk for cancer.Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.
P2860
Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cell-free DNA as a prognostic ...... tereotactic body radiotherapy.
@en
type
label
Cell-free DNA as a prognostic ...... tereotactic body radiotherapy.
@en
prefLabel
Cell-free DNA as a prognostic ...... tereotactic body radiotherapy.
@en
P2093
P2860
P50
P1433
P1476
Cell-free DNA as a prognostic ...... tereotactic body radiotherapy.
@en
P2093
Carlo Furlan
Carlo Gobitti
Emilio Minatel
Giancarlo Basaglia
Marco Trovò
Maria Teresa Bortolin
Rosamaria Tedeschi
P2860
P304
P356
10.3109/1354750X.2015.1094139
P577
2015-11-02T00:00:00Z